Lipocine Inc. 8-K

What Happened
Lipocine Inc. (LPCN) filed a Form 8-K dated February 18, 2026, reporting an "Other Events" disclosure. The company attached a corporate presentation as Exhibit 99.1 to the filing and included the Inline XBRL cover page (Exhibit 104). No other Form 8-K items (such as earnings, executive changes, or material agreements) were reported in this filing.

Key Details

• Filing date: February 18, 2026 (Form 8-K).
• Item reported: 8.01 (Other Events) — Corporate presentation filed as Exhibit 99.1.
• Exhibits listed: 99.1 (Corporate Presentation) and 104 (Cover Page Interactive Data File).
• The filing does not disclose earnings, revenue figures, executive appointments, or other material corporate actions.

Why It Matters
This 8-K provides investors with Lipocine’s latest corporate presentation, which may contain updates on strategy, product pipeline, or business highlights. The filing itself does not report financial results or corporate changes, so investors should review Exhibit 99.1 on the SEC EDGAR site for specific details included in the presentation.